Global Antigout Drug Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI236327
- May 03, 2019
- Global
- 92 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Antigout Drug market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Antigout Drug market."
Gout is a form of inflammatory arthritis characterized by recurrent attacks of a red, tender, hot, and swollen joint. Pain typically comes on rapidly in less than twelve hours.The joint at the base of the big toe is affected in about half of cases.It may also result in tophi, kidney stones, or urate nephropathy.
The global Antigout Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antigout Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antigout Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Takeda
Aspen
heumann pharma
Teijin Pharma
Horizon Pharma
Novartis
WanBang
Jiangsu Hengrui Medicine
Rotamreddy
KPC Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Febuxostat
Benzbromarone
Allopurinol
Colchicine
Segment by Application
Acute Gout
Chronic Gout
Table of Contents
Executive Summary
1 Antigout Drug Market Overview
1.1 Product Overview and Scope of Antigout Drug
1.2 Antigout Drug Segment by Type
1.2.1 Global Antigout Drug Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Febuxostat
1.2.3 Benzbromarone
1.2.4 Allopurinol
1.2.5 Colchicine
1.3 Antigout Drug Segment by Application
1.3.1 Antigout Drug Consumption Comparison by Application (2014-2025)
1.3.2 Acute Gout
1.3.3 Chronic Gout
1.4 Global Antigout Drug Market by Region
1.4.1 Global Antigout Drug Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Antigout Drug Market Size
1.5.1 Global Antigout Drug Revenue (2014-2025)
1.5.2 Global Antigout Drug Production (2014-2025)
2 Global Antigout Drug Market Competition by Manufacturers
2.1 Global Antigout Drug Production Market Share by Manufacturers (2014-2019)
2.2 Global Antigout Drug Revenue Share by Manufacturers (2014-2019)
2.3 Global Antigout Drug Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Antigout Drug Production Sites, Area Served, Product Types
2.5 Antigout Drug Market Competitive Situation and Trends
2.5.1 Antigout Drug Market Concentration Rate
2.5.2 Antigout Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Antigout Drug Production Market Share by Regions
3.1 Global Antigout Drug Production Market Share by Regions
3.2 Global Antigout Drug Revenue Market Share by Regions (2014-2019)
3.3 Global Antigout Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Antigout Drug Production
3.4.1 North America Antigout Drug Production Growth Rate (2014-2019)
3.4.2 North America Antigout Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Antigout Drug Production
...
| read more...
Related Reports
